Brought to you by 
Kyowa Hakko to pay £292mm for spec pharma ProStrakan
14 Jun 2011
Executive Summary
Kirin Holdings Co. Ltd.’s pharma group Kyowa Hakko Kirin Co. Ltd. is attempting to acquire public Scottish company ProStrakan Group PLC for £292mm ($473mm) in cash. Kyowa will pay £1.30 per share, a 31% premium to the ten-day average prior to November 12, 2010, when ProStrakan began its offer period. ProStrakan said it had received bids from several suitors over the past few months, including an unsolicited £1-per-share offer from Norgine.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Kyowa Hakko to pay £292mm for spec pharma ProStrakan
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice